Next Article in Journal
Next Generation DNA Sequencing and the Future of Genomic Medicine
Previous Article in Journal
Asymmetric Introgressive Hybridization Among Louisiana Iris Species
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 1
Issue 1
10.3390/genes1010023
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

An Examination of KCNE1 Mutations and Common Variants in Chronic Tinnitus

by
Philipp G. Sand
1,*,
Alexander Luettich
2,
Tobias Kleinjung
3,
Goeran Hajak
1 and
Berthold Langguth
1
1
Department of Psychiatry, University of Regensburg, Universitaetsstr. 84, 93042 Regensburg, Germany
2
Experimental and Clinical Neurosciences Graduate Program, University of Regensburg, Germany
3
Department of Otorhinolaryngology, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany
*
Author to whom correspondence should be addressed.
Genes 2010, 1(1), 23-37; https://doi.org/10.3390/genes1010023
Submission received: 29 March 2010 / Revised: 23 April 2010 / Accepted: 27 April 2010 / Published: 28 April 2010
Browse Figures
Versions Notes

Abstract

:
Chronic tinnitus is a highly prevalent and often incapacitating condition frequently associated with sensorineural hearing loss. While its etiology remains incompletely understood there is a growing awareness of genetic factors that predispose to, or aggravate chronic tinnitus. Candidate genes for the disorder include KCNE1, a potassium channel subunit gene that has been implicated in maturation defects of central vestibular neurons, in Menière's disease, and in noise-induced hearing loss. 201 Caucasian outpatients with a diagnosis of chronic tinnitus were systematically screened for mutations in the KCNE1 open reading frame and in the adjacent sequence by direct sequencing. Allele frequencies were determined for 46 known variants, plus two novel KCNE1 mutations. These comprised one missense substitution (V47I) in the highly conserved region encoding the KCNE1 transmembrane domain, and one rare variant in the gene's 3'UTR. When genotypes were grouped assuming dominance of the minor alleles, no significant genotype or compound genotype effects were observed on tinnitus severity. The newly identified V47I substitution argues in favor of an enlarged spectrum of mutations in hearing disorders. However, with regard to allele frequencies in healthy control populations from earlier studies, more common KCNE1 variants are unlikely to play a major role in chronic tinnitus. Further investigations are invited to address variation in additional channel subunits as possible risk factors in tinnitus.

1. Introduction

Tinnitus refers to a sensation of sound perceived in the head or in the ears without any evident external stimulus. The condition may cause significant discomfort and may interfere with daily activities, emotional state and sleep. Depending on the specifications used in self-assessments of tinnitus, estimates of prevalence in the general population vary from 3% to 30% in epidemiological studies [1,2]. To date, the etiology remains largely unknown but an established association with various forms of sensorineural hearing impairment and frequent precipitation by noise exposure suggest substantial overlap with pathologies of the inner ear [3], and related disorders of auditory information processing [4]. In contrast to well-defined environmental risk factors, however, only limited data are currently available on genetic traits that may predispose to common, chronic forms of tinnitus (reviewed by [5]).
Voltage-gated ion channels that directly control the neural transmission of auditory input are strong candidates for the pathophysiology of tinnitus. In the inner ear, sensory neurons are surrounded by endolymph rich in KCl and constantly recycle potassium for the generation of endocochlear potentials [6]. K+ homeostasis requires coexpression of α and β subunits of pore-forming channel proteins in the lateral wall of the cochlea and the vestibular labyrinth [7]. Dysfunctional channels and mutations in the gene encoding the KCNQ4 subunit are a hallmark of autosomal dominant deafness 2A [8]. Mutated KCNQ1 α and KCNE1 β subunits, in turn, cause syndromal deafness with abnormal cardiac ventricular repolarization (Jervell and Lange-Nielsen Syndrome, JLNS) [9,10,11]. A prominent role of the KCNE1 subunit in auditory perception is underscored by degeneration of sensory hair cells and deafness in KCNE1 knock-out animals [12], plus deleterious effects of a spontaneous KCNE1 null mutation on hearing in mice [13]. In addition, KCNE1 regulates trafficking and activation of another potassium channel, KCNH3, in the cerebral cortex and in other parts of the brain that have been implicated in disorders of excitability and synchronization [14].
Common genetic variation in potassium channel genes has recently been proposed as a possible risk modifier in Menière's disease [15], in age-related hearing loss [16], and in noise-induced hearing loss [17,18], i.e., in conditions that typically co-occur with tinnitus [19]. We hypothesized that primary chronic tinnitus could be part of the phenotypic spectrum associated with KCNE1, and systematically screened the open reading frame for variants in subjects who had experienced tinnitus for a minimum of six months.

2. Results and Discussion

We identified four coding and three noncoding variants with minor allele frequencies ranging from 0.002 to 0.45 (Table 1, Figure 1). These included one silent polymorphism, S28S, two known missense substitutions, S38G and D85N, plus a novel missense variant, V47I (Figure 2a). This newly identified substitution maps to a highly conserved region encoding the KCNE1 transmembrane domain (TMD) (Figure 3). Of the SNPs located in the 3' untranslated region, two had been previously described (rs2070357 and rs41314071) and one was a novel transversion occurring in <1% of alleles (Figure 2b). Three common haplotypes were defined by markers rs17846179 (S38G) and rs2070357: fGG = 0.544, fAA = 0.358, and fAG = 0.097.
Table
Table 1. Observed allele frequencies for the KCNE1 sequence screened in subjects with chronic tinnitus (N=201). Seven non-monomorphic variants are shaded.
Table 1. Observed allele frequencies for the KCNE1 sequence screened in subjects with chronic tinnitus (N=201). Seven non-monomorphic variants are shaded.
dbSNP ID chr21 position major>minor allelesavariant amino acid minor allele frequency in chronic tinnitus homozygous/heterozygous carriers of the minor allele (pHWE)
rs28933384 35,821,913 C>T T7I 0.000 -
- 35,821,910 C>T A8V 0.000 -
- 35,821,904 C>T T10M 0.000 -
- 35,821,903 G>A T10T 0.000 -
- 35,821,883 G>A W17X 0.000 -
- 35,821,874 C>T T20I 0.000 -
- 35,821,850 C>T S28L 0.000 -
rs17173510 35,821,849 G>A S28S 0.002 0/1 (0.972)
rs17857111 35,821,838 G>A R32H 0.000 -
- 35,821,826 G>A R36H 0.000 -
rs1805127 35,821,821 G>A G38S 0.359 28/88 (0.498)
- 35,821,794 G>T V47F 0.000 -
(novel) 35,821,794 G>A V47I 0.002 0/1 (0.972)
- 35,821,780-1 TG>AC L51H 0.000 -
rs17173509 35,821,778 G>C G52A 0.000 -
- 35,821,779 G>A G52R 0.000 -
- 35,821,775 T>C F53S 0.000 -
- 35,821,774 C>T F53F 0.000 -
rs17173508 35,821,771 C>T F54F 0.000 -
- 35,821,770 G>A G55S 0.000 -
- 35,821,761 A>C T58P 0.000 -
- 35,821,757 T>C L59P 0.000 -
- 35,821,734 C>T R67C 0.000 -
- 35,821,733 G>A R67H 0.000 -
- 35,821,727 A>G K69R 0.000 -
- 35,821,724 A>T K70M 0.000 -
- 35,821,723 G>C K70N 0.000 -
- 35,821,712 C>T S74L 0.000 -
- 35,821,708 C>T N75N 0.000 -
- 35,821,707 G>A D76N 0.000 -
- 35,821,693 C>G V80V 0.000 -
- 35,821,693 C>T V80V 0.000 -
- 35,821,691 A>G Y81C 0.000 -
- 35,821,686 G>A E83K 0.000 -
rs1805128 35,821,680 G>A D85N 0.007 0/3 (0.915)
- 35,821,674 T>C W87R 0.000 -
- 35,821,641 C>T R98W 0.000 -
rs17853625 35,821,615 C>A C106X 0.000 -
- 35,821,608 G>A V109I 0.000 -
- 35,821,584 C>T Q117X 0.000 -
- 35,821,559 C>T T125M 0.000 -
- 35,821,554 C>A P127T 0.000 -
rs2070357 35,821,419 G>A - 0.455 42/98 (0.865)
rs41314071 35,821,411 A>G - 0.045 1/16 (0.328)
rs41314069 35,821,376 C>A - 0.000 -
(novel) 35,821,347 C>G - 0.003 0/1 (0.972)
rs41312371 35,821,283 A>C - 0.000 -
rs41314807 35,821,275 C>T - 0.000 -
a all alleles refer to the chr21 minus strand
Genes 01 00023 g001 550
Figure 1. LD plot and R2 values for the seven KCNE1 variants identified.
Figure 1. LD plot and R2 values for the seven KCNE1 variants identified.
Genes 01 00023 g001
Genes 01 00023 g002 550
Figure 2. Chromatograms of the newly identified KCNE1 Val47Ile (a) and noncoding C>G substitution in the 3'UTR (b).
Figure 2. Chromatograms of the newly identified KCNE1 Val47Ile (a) and noncoding C>G substitution in the 3'UTR (b).
Genes 01 00023 g002
Genes 01 00023 g003 550
Figure 3. Comparative analysis of the KCNE1 genomic sequence screened. Basewise conservation scores obtained with the Multiz alignment are plotted against the physical position on chromosome 21 for 31 placental mammals featured in the UCSC Genome Browser. The newly identified V47I mutation maps to the highly conserved KCNE1 transmembrane domain delimited by residues 44 and 60 [61].
Figure 3. Comparative analysis of the KCNE1 genomic sequence screened. Basewise conservation scores obtained with the Multiz alignment are plotted against the physical position on chromosome 21 for 31 placental mammals featured in the UCSC Genome Browser. The newly identified V47I mutation maps to the highly conserved KCNE1 transmembrane domain delimited by residues 44 and 60 [61].
Genes 01 00023 g003
For all coding variants identified, reference allele frequencies in healthy Caucasian populations were obtained from the literature and from variation databases. Data from a Polish control population [26] were incongruent with all remaining studies and considered to be misleading. When allele frequencies in the other control populations were compared to the respective frequencies in tinnitus subjects assuming all controls were tinnitus-free, no significant difference was noted for S28S, G38S, V47I, and D85N (Table 2). For non-coding variants, a comparison of allele frequencies in tinnitus patients with reference frequencies retrieved from dbSNP [27] (HapMap CEU, N=59, rs2070357, plus the Coriell Cell Repository Caucasian panel, N=47, rs2070357 and rs41314071) with the Genome Variation Server [28] gave non-significant association results (data not shown). Based on the entire sample of tinnitus patients and nine Caucasian control populations, however, a weak effect on the susceptibility to tinnitus cannot be entirely ruled out. Thus power simulations indicated that we should require over 12,500 patients in order to exclude a modifying role of G38S on allelic risk with a statistical power of 0.8.
Table
Table 2. Reference frequencies of KCNE1 coding variants in Caucasians as reported for unrelated, healthy controls. Of these, five control populations ([36,52,58,59,60], total N=938) have been systematically screened for mutations and serve as a reference for the novel V47I variant. One further study involving 100 Canadian controls [31] was excluded as allele frequencies were missing. Data reported by Prystupa et al. [26] are given in brackets to indicate a likely misallocation of major and minor alleles. When this figure is excluded, exact tests of allelic association conducted with reference populations and the tinnitus sample give non-significant (n.s.) results throughout.
Table 2. Reference frequencies of KCNE1 coding variants in Caucasians as reported for unrelated, healthy controls. Of these, five control populations ([36,52,58,59,60], total N=938) have been systematically screened for mutations and serve as a reference for the novel V47I variant. One further study involving 100 Canadian controls [31] was excluded as allele frequencies were missing. Data reported by Prystupa et al. [26] are given in brackets to indicate a likely misallocation of major and minor alleles. When this figure is excluded, exact tests of allelic association conducted with reference populations and the tinnitus sample give non-significant (n.s.) results throughout.
healthy controls (Nunrelated) source fSer28(TCA)vs. fSer28(TCA) in present study (p) fSer38vs. fSer38 in present study (p) fIle47vs. fIle47 in present study (p) fAsn85vs. fAsn85 in present study (p)
U.S., European descent (187) [36] 0.000 n.s. - - 0.000 n.s. - -
Dutch (32) [58] 0.000 n.s. 0.33 n.s. 0.000 n.s. 0.000 n.s.
German (141) [59] - - - - 0.000 n.s. - -
French (398) [60,62] 0.000 n.s. 0.372 n.s. 0.000 n.s. 0.018 n.s.
Polish (129) [26] - - (0.582) (<0.0001) - - - -
German (3,916) [63] - - 0.368 n.s. - - - -
Finnish (5,043) [64] - - - - - - 0.014 n.s.
U.S., European descent (180) [51] 0.006 n.s. 0.378 n.s. 0.000 n.s. 0.008 n.s.
Central Europeans (59) [27] HapMap CEU - - 0.381 n.s. - - 0.008 n.s.
Caucasian panel (47) [27] Coriell Cell Repository R31 CAU - - 0.394 n.s. - - 0.021 n.s.
With regard to the severity of symptoms, TQ scores followed a Gaussian distribution (Figure 4) and averaged 38.3 ±16.3 (mean ±SD) out of 84 points (N=183). By this measure, tinnitus was rated 'mild' (0 to 30 points) in 34.4%, 'moderate' (31 to 46 points) in 33.9%, 'severe' (47 to 59 points) in 20.2%, and 'extreme' (60 to 84 points) in 11.5% of subjects investigated. Carrier of the V47I substitution was a 66 year-old woman who self-graded her tinnitus as 'extreme', scoring 62 out of 84 points on the TQ scale, and above the 91st percentile. She had suffered from tinnitus for 4.5 years but did not present with hearing impairment. In three individuals heterozygous for the D85N substitution (f=0.007), tinnitus severity was rated 'moderate' (36, 38 and 44 points). Neither V47I nor any other genotype or compound genotype predicted tinnitus severity regardless of concomitant hearing impairment (ANOVA, F=0.89, df=7, p>0.51).
Genes 01 00023 g004 550
Figure 4. Distribution of TQ scores in 183 subjects with chronic tinnitus.
Figure 4. Distribution of TQ scores in 183 subjects with chronic tinnitus.
Genes 01 00023 g004
Eight additional KCNE1 variants listed in dbSNP were not confirmed in our sample (rs28933384, rs17857111, rs17173509, rs17173508, rs17853625, rs41314069, rs41312371, and rs41314807). A number of previously reported KCNE1 mutations were also excluded: A8V [29,30], T10M [30], T10T [31], W17X [30], T20I [32], S28L [30,33], R36H [34], V47F [35], L51H [35], G52A [36], G52R [37], F53S [34], G55S [30], T58P [11,30], L59P [11,30], R67C [30], R67H [30], K69R [36], K70M [30], K70N [38], S74L [39,40], N75N [41], D76N [30,39,41,42,43,44,45], V80V [46,47], Y81C [38,48], E83K [30], W87R [35], R98W [29,39,49], V109I [36,50], Q117X [30], T125M [30], and P127T [40,51] (Table 1).
Allele frequencies of known coding variants compare to data previously reported in healthy Caucasian populations with one exception [26]. In the latter study, inverted allele counts suggest a misallocation of G38 and S38 (Table 2). The present lack of significant differences in KCNE1 coding allele frequencies of control subjects and tinnitus patients is thus based on a comparison with nine populations previously investigated. While this approach was not adequately powered to rule out a causative role of gene variants in tinnitus, our results tend to further disprove KCNE1 variation as a risk factor in pathologies with complex modes of inheritance. For Menière's disease, Doi et al. [15] had originally claimed an association with S38 in an Asian population but recent work has cast doubt on the validity of these findings by exposing stratification artefacts and by providing independent negative association results for both G38S and D85N [52]. With regard to noise-induced hearing loss, a risk-enhancing effect of the G38 allele disappeared after correcting for multiple testing [17]. A recent attempt to corroborate this weak association in a separate Caucasian sample was unsuccessful [18]. The D85 allele, in turn, has been labeled both 'risk-enhancing' and 'protective' in noise-induced hearing loss [17,18]. Others have classified the substitution as an infrequent polymorphism rather than a disease-causing mutation [36,53,54].
To date, in vitro analyses have failed to resolve the controversies surrounding a putative in vivo impact of G38S and D85N on potassium conductance. The G38S substitution did not show any major effects on KCNE1 glycolsylation [55] but has not been examined in a heterologous expression system. Patch-clamp experiments with Chinese hamster ovarian cells and Xenopus laevis oocytes expressing D85N have yielded contradictory effects on opening of the potassium channel, i.e., a gain of function [17] and a loss of function [40,56]. While the newly identified V47I mutation awaits further characterization in expression models, an earlier study has addressed a compound heterozygous TMD substitution involving the same residue (V47F + L51H) in a case of mild JLNS [35]. Coexpression of V47F + L51H mutant cRNA in Xenopus oocytes gave KCNQ1 activation currents indistinguishable from those elicited by simple KCNE1 V47F mutants, and led the authors to assume that the phenotype was primarily caused by functional effects of V47F.
KCNE1 TMD missense mutations have been described in cases of JLNS (V47F, L51H, T58P, and L59P), long QT syndrome (G52R, F53S, and G55S), and on one occasion, in an anonymous subject classified as 'apparently healthy' (G52A). To judge by the non-identification of V47I in systematic screenings of healthy controls, V47I is rare in the Caucasian general population (Table 2) and has not been observed either in African American or in Asian control populations [36,38]. Pending further characterization of V47I effects on KCNE1 function in vitro, a causative role in tinnitus etiology remains speculative. Extreme symptom severity in the mutation carrier would appear to strengthen the genotype-phenotype relationship but family data and additional data on cardiac repolarization were unavailable. In analogy to the established comorbidity of hearing disorders and arryhthmias in JLNS, the spectrum of monogenic disorders associated with KCNE1 mutations may involve rare cases of tinnitus. It is noteworthy that a 'cardiac irregularity' is also mentioned as an accessory symptom in one of the earliest scientific accounts of tinnitus [57].

3. Experimental Section

In 201 German outpatients (152 men and 49 women, age 49.9 ±12.0 yrs, mean ±SD) consulting for chronic tinnitus, the diagnosis was confirmed by a detailed neurootological examination including otoscopy, stapedius reflexes, middle ear pressure measurements and pure tone audiometry. For the present study, only patients with subjective tinnitus were included. Tinnitus severity was assessed by the Tinnitus Questionnnaire (TQ) [20] in 183 patients (90.6%).
Genomic DNA was extracted from lymphocytes using standard procedures prior to amplification of the KCNE1 coding region by PCR. Briefly, a 765bp amplicon was generated using the following oligomers: 5'-TTT TGA TTT GGG GTT GCA T-3' (forward) and 5'-GCT AGC TGC AAG GGA GTC T-3' (reverse). PCR products were purified with ExoSAP-IT (GE Healthcare, Freiburg, Germany) for custom sequencing and for the identification of DNA variants by comparison with the human genome reference (Genome Reference Consortium Build 37, February 2009 release). Multiple sequence alignments were conducted with DNA Dynamo 1.0 (Blue Tractor Software, UK). STATA 8.0 (Stata Corporation, College Station, TX, USA) was used for descriptive statistics, for conducting tests of allelic association, and for modeling effects of KCNE1 genotypes on TQ scores by ANOVA. To this avail, genotypes were dichotomized using a dominant model for minor alleles. KCNE1 allele frequencies from reference populations were compared to the present data using Fisher's exact test. The Shapiro-Wilk statistic served to test the null hypothesis of normally distributed TQ scores. The level of statistical significance was set at p=0.05. All p values are uncorrected for multiple testing.
For estimating the functionality of sequence variants observed in our sample, evolutionary conservation was assessed with a phylogenetic hidden Markov model-based method, phastCons, that describes the process of DNA substitution at each site in a genome and the way this process changes from one site to the next [21]. Genomic sequences from 31 placental mammals were aligned to the human reference delimited by forward and reverse primers using a Threaded Blockset Aligner [22] as implemented in the conservation track of the UCSC Genome Browser [23]. Power simulations were conducted with PS 1.0.15 [24]. Linkage disequilibrium and conformity of genotype distributions with the Hardy-Weinberg equilibrium was measured with HaploView 4.2 [25].

4. Conclusions

Taken together, the present findings lend little support to the notion of common KCNE1 variants as possible risk modifiers of chronic tinnitus, but suggest the existence of syndromal subtypes with underlying channelopathies and invite more detailed investigations of other genes relevant to potassium homeostasis. Should such tinnitus channelopathies be confirmed in the future, the existing options for prevention and treatment of the disorder will need to be reappraised.

References and Notes

  1. Sanchez, L. The epidemiology of tinnitus. Audiol. Med. 2004, 2, 8–17. [Google Scholar] [CrossRef]
  2. Hoffman, H.J.; Reed, G.W. Epidemiology of Tinnitus. In Tinnitus: Theory and Management; Snow, J.B., Ed.; BC Decker: London, UK, 2004; pp. 16–41. [Google Scholar]
  3. Eggermont, J.J. Pathophysiology of tinnitus. Prog. Brain Res. 2007, 166, 19–35. [Google Scholar] [CrossRef]
  4. Attias, J.; Furman, V.; Shemesh, Z.; Bresloff, I. Impaired brain processing in noise-induced tinnitus patients as measured by auditory and visual event-related potentials. Ear Hear. 1996, 17, 327–333. [Google Scholar]
  5. Sand, P.G.; Langguth, B.; Kleinjung, T.; Eichhammer, P. Genetics of chronic tinnitus. Prog. Brain Res. 2007, 166, 159–168. [Google Scholar] [CrossRef]
  6. Wangemann, P. K+ cycling and the endocochlear potential. Hear Res. 2002, 165, 1–9. [Google Scholar] [CrossRef]
  7. Hibino, H.; Nin, F.; Tsuzuki, C.; Kurachi, Y. How is the highly positive endocochlear potential formed? The specific architecture of the stria vascularis and the roles of the ion-transport apparatus. Pflugers Arch. 2010, 459, 521–533. [Google Scholar] [CrossRef]
  8. Coucke, P.J.; Van Hauwe, P.; Kelley, P.M.; Kunst, H.; Schatteman, I.; Van Velzen, D.; Meyers, J.; Ensink, R.J.; Verstreken, M.; Declau, F.; Marres, H.; Kastury, K.; Bhasin, S.; McGuirt, W.T.; Smith, R.J.H.; Cremers, C.W.R.J.; Van de Heyning, P.; Willems, P.J.; Smith, S.D.; Van Camp, G. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum. Molec. Genet. 1999, 8, 1321–1328. [Google Scholar] [CrossRef]
  9. Jervell, A.; Lange-Nielsen, F. Congenital deaf-mutism, functional heart disease with prolongation of Q-T interval and sudden death. Am. Heart J. 1957, 54, 59–68. [Google Scholar] [CrossRef]
  10. Neyroud, N.; Tesson, F.; Denjoy, I.; Leibovici, M.; Donger, C.; Barhanin, J.; Faure, S.; Gary, F.; Coumel, P.; Petit, C.; Schwartz, K.; Guicheney, P. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nature Genet. 1997, 15, 186–189. [Google Scholar] [CrossRef]
  11. Tyson, J.; Tranebjaerg, L.; Bellman, S.; Wren, C.; Taylor, J.F.; Bathen, J.; Aslaksen, B.; Sørland, S.J.; Lund, O.; Malcolm, S.; Pembrey, M.; Bhattacharya, S.; Bitner-Glindzicz, M. IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. Hum. Mol. Genet. 1997, 6, 2179–2185. [Google Scholar] [CrossRef]
  12. Vetter, D.E.; Mann, J.R.; Wangemann, P.; Liu, J.; McLaughlin, K.J.; Lesage, F.; Marcus, D.C.; Lazdunski, M.; Heinemann, S.F.; Barhanin, J. Inner ear defects induced by null mutation of the isk gene. Neuron 1996, 17, 1251–1264. [Google Scholar] [CrossRef]
  13. Letts, V.A.; Valenzuela, A.; Dunbar, C.; Zheng, Q.Y.; Johnson, K.R.; Frankel, W.N. A new spontaneous mouse mutation in the Kcne1 gene. Mamm. Genome 2000, 11, 831–835. [Google Scholar] [CrossRef]
  14. Clancy, S.M.; Chen, B.; Bertaso, F.; Mamet, J.; Jegla, T. KCNE1 and KCNE3 beta-subunits regulate membrane surface expression of Kv12.2 K(+) channels in vitro and form a tripartite complex in vivo. PLoS One 2009, 4, e6330. [Google Scholar]
  15. Doi, K.; Sato, T.; Kuramasu, T.; Hibino, H.; Kitahara, T.; Horii, A.; Matsushiro, N.; Fuse, Y.; Kubo, T. Ménière's disease is associated with single nucleotide polymorphisms in the human potassium channel genes, KCNE1 and KCNE3. ORL J. Otorhinolaryngol. Relat. Spec. 2005, 67, 289–293. [Google Scholar] [CrossRef]
  16. Van Eyken, E.; Van Laer, L.; Fransen, E.; Topsakal, V.; Lemkens, N.; Laureys, W.; Nelissen, N.; Vandevelde, A.; Wienker, T.; Van De Heyning, P.; Van Camp, G. KCNQ4: a gene for age-related hearing impairment? Hum. Mutat. 2006, 27, 1007–1016. [Google Scholar] [CrossRef]
  17. Van Laer, L.; Carlsson, P.I.; Ottschytsch, N.; Bondeson, M.L.; Konings, A.; Vandevelde, A.; Dieltjens, N.; Fransen, E.; Snyders, D.; Borg, E.; Raes, A.; Van Camp, G. The contribution of genes involved in potassium-recycling in the inner ear to noise-induced hearing loss. Hum. Mutat. 2006, 27, 786–795. [Google Scholar] [CrossRef]
  18. Pawelczyk, M; Van Laer, L; Fransen, E. Analysis of gene polymorphisms associated with K ion circulation in the inner ear of patients susceptible and resistant to noise-induced hearing loss. Ann. Hum. Genet. 2009, 73, 411–421. [Google Scholar] [CrossRef]
  19. Axelsson, A.; Sandh, A. Tinnitus in noise-induced hearing loss. Br. J. Audiol. 1985, 19, 271–276. [Google Scholar] [CrossRef]
  20. Goebel, G.; Hiller, W. The tinnitus questionnaire.A standard instrument for grading the degree of tinnitus. Results of a multicenter study with the tinnitus questionnaire. HNO 1994, 42, 166–172. [Google Scholar]
  21. Siepel, A.; Bejerano, G.; Pedersen, J.S.; Hinrichs, A.S.; Hou, M.; Rosenbloom, K.; Clawson, H.; Spieth, J.; Hillier, L.W.; Richards, S.; Weinstock, G.M.; Wilson, R.K.; Gibbs, R.A.; Kent, W.J.; Miller, W.; Haussler, D. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005, 15, 1034–1050. [Google Scholar] [CrossRef]
  22. Blanchette, M.; Kent, W.J.; Riemer, C.; Elnitski, L.; Smit, A.F.; Roskin, K.M.; Baertsch, R.; Rosenbloom, K.; Clawson, H.; Green, E.D.; Haussler, D.; Miller, W. Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res. 2004, 14, 708–715. [Google Scholar] [CrossRef]
  23. Rhead, B.; Karolchik, D.; Kuhn, R.M.; Hinrichs, A.S.; Zweig, A.S.; Fujita, P.A.; Diekhans, M.; Smith, K.E.; Rosenbloom, K.R.; Raney, B.J.; Pohl, A.; Pheasant, M.; Meyer, L.R.; Learned, K.; Hsu, F.; Hillman-Jackson, J.; Harte, R.A.; Giardine, B.; Dreszer, T.R.; Clawson, H.; Barber, G.P.; Haussler, D.; Kent, W.J. The UCSC Genome Browser database: update 2010. Nucleic Acids Res. 2010, 38, D613–619. [Google Scholar] [CrossRef]
  24. Dupont, W.D.; Plummer, W.D., Jr. Power and sample size calculations: a review and computer program. Control Clin. Trials 1990, 11, 116–128. [Google Scholar] [CrossRef]
  25. Barrett, J.C.; Fry, B.; Maller, J.; Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21, 263–265. [Google Scholar] [CrossRef]
  26. Prystupa, A.; Dzida, G.; Myśliński, W.; Małaj, G.; Lorenc, T. MinK gene polymorphism in the pathogenesis of lone atrial fibrillation. Kardiol. Pol. 2006, 64, 1205–1211. [Google Scholar]
  27. Sayers, E.W.; Barrett, T.; Benson, D.A.; Bolton, E.; Bryant, S.H.; Canese, K.; Chetvernin, V.; Church, D.M.; Dicuccio, M.; Federhen, S.; Feolo, M.; Geer, L.Y.; Helmberg, W.; Kapustin, Y.; Landsman, D.; Lipman, D.J.; Lu, Z.; Madden, T.L.; Madej, T.; Maglott, D.R.; Marchler-Bauer, A.; Miller, V.; Mizrachi, I.; Ostell, J.; Panchenko, A.; Pruitt, K.D.; Schuler, G.D.; Sequeira, E.; Sherry, S.T.; Shumway, M.; Sirotkin, K.; Slotta, D.; Souvorov, A.; Starchenko, G.; Tatusova, T.A.; Wagner, L.; Wang, Y.; John Wilbur, W.; Yaschenko, E.; Ye, J. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2010, 38, D5-16. [Google Scholar] [CrossRef]
  28. Genome Variation Server. Available online: http://gvs.gs.washington.edu/GVS (accessed 4 March 2010).
  29. Ohno, S.; Zankov, D.P.; Yoshida, H.; Tsuji, K.; Makiyama, T.; Itoh, H.; Akao, M.; Hancox, J.C.; Kita, T.; Horie, M. N- and C-terminal KCNE1 mutations cause distinct phenotypes of long QT syndrome. Heart Rhythm 2007, 4, 332–340. [Google Scholar] [CrossRef]
  30. Kapplinger, J.D.; Tester, D.J.; Salisbury, B.A.; Carr, J.L.; Harris-Kerr, C.; Pollevick, G.D.; Wilde, A.A.; Ackerman, M.J. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm 2009, 6, 1297–1303. [Google Scholar] [CrossRef]
  31. Koo, S.H.; Ho, W.F.; Lee, E.J. Genetic polymorphisms in KCNQ1, HERG, KCNE1 and KCNE2 genes in the Chinese, Malay and Indian populations of Singapore. Br. J. Clin. Pharmacol. 2006, 61, 301–308. [Google Scholar] [CrossRef]
  32. Millat, G.; Kugener, B.; Chevalier, P.; Chahine, M.; Huang, H.; Malicier, D.; Rodriguez-Lafrasse, C.; Rousson, R. Contribution of long-QT syndrome genetic variants in sudden infant death syndrome. Pediatr. Cardiol. 2009, 30, 502–509. [Google Scholar] [CrossRef]
  33. Shim, S.H.; Ito, M.; Maher, T.; Milunsky, A. Gene sequencing in neonates and infants with the long QT syndrome. Genet. Test 2005, 9, 281–284. [Google Scholar]
  34. Napolitano, C.; Priori, S.G.; Schwartz, P.J.; Bloise, R.; Ronchetti, E.; Nastoli, J.; Bottelli, G.; Cerrone, M.; Leonardi, S. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. J.A.M.A. 2005, 294, 2975–2980. [Google Scholar] [CrossRef]
  35. Bianchi, L.; Shen, Z.; Dennis, A.T.; Priori, S.G.; Napolitano, C.; Ronchetti, E.; Bryskin, R.; Schwartz, P.J.; Brown, A.M. Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome. Hum. Mol. Genet. 1999, 8, 1499–1507. [Google Scholar] [CrossRef]
  36. Ackerman, M.J.; Tester, D.J.; Jones, G.S.; Will, M.L.; Burrow, C.R.; Curran, M.E. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin. Proc. 2003, 78, 1479–1487. [Google Scholar] [CrossRef]
  37. Ma, L.; Lin, C.; Teng, S.; Chai, Y.; Bähring, R.; Vardanyan, V.; Li, L.; Pongs, O.; Hui, R. Characterization of a novel Long QT syndrome mutation G52R-KCNE1 in a Chinese family. Cardiovasc. Res. 2003, 59, 612–619. [Google Scholar] [CrossRef]
  38. Lai, L.P.; Su, Y.N.; Hsieh, F.J.; Chiang, F.T.; Juang, J.M.; Liu, Y.B.; Ho, Y.L.; Chen, W.J.; Yeh, S.J.; Wang, C.C.; Ko, Y.L.; Wu, T.J.; Ueng, K.C.; Lei, M.H.; Tsao, H.M.; Chen, S.A.; Lin, T.K.; Wu, M.H.; Lo, H.M.; Huang, S.K.; Lin, J.L. Denaturing high-performance liquid chromatography screening of the long QT syndrome-related cardiac sodium and potassium channel genes and identification of novel mutations and single nucleotide polymorphisms. J. Hum. Genet. 2005, 50, 490–496. [Google Scholar] [CrossRef]
  39. Splawski, I.; Tristani-Firouzi, M.; Lehmann, M.H.; Sanguinetti, M.C.; Keating, M.T. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat. Genet. 1997, 17, 338–340. [Google Scholar] [CrossRef]
  40. Westenskow, P.; Splawski, I.; Timothy, K.W.; Keating, M.T.; Sanguinetti, M.C. Compound mutations: a common cause of severe long-QT syndrome. Circulation 2004, 109, 1834–1841. [Google Scholar] [CrossRef]
  41. Berge, K.E.; Haugaa, K.H.; Früh, A.; Anfinsen, O.G.; Gjesdal, K.; Siem, G.; Oyen, N.; Greve, G.; Carlsson, A.; Rognum, T.O.; Hallerud, M.; Kongsgård, E.; Amlie, J.P.; Leren, T.P. Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers. Scand. J. Clin. Lab. Invest. 2008, 68, 362–368. [Google Scholar] [CrossRef]
  42. Schulze-Bahr, E.; Wang, Q.; Wedekind, H.; Haverkamp, W.; Chen, Q.; Sun, Y.; Rubie, C.; Hördt, M.; Towbin, J.A.; Borggrefe, M.; Assmann, G.; Qu, X.; Somberg, J.C.; Breithardt, G.; Oberti, C.; Funke, H. KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat. Genet. 1997, 17, 267–268. [Google Scholar] [CrossRef]
  43. Duggal, P.; Vesely, M.R.; Wattanasirichaigoon, D.; Villafane, J.; Kaushik, V.; Beggs, A.H. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome. Circulation 1998, 97, 142–146. [Google Scholar] [CrossRef]
  44. Tester, D.J.; Will, M.L.; Haglund, C.M.; Ackerman, M.J. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2005, 2, 507–517. [Google Scholar] [CrossRef]
  45. Tester, D.J.; Arya, P.; Will, M.; Haglund, C.M.; Farley, A.L.; Makielski, J.C.; Ackerman, M.J. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing. Heart Rhythm 2006, 3, 800–805. [Google Scholar] [CrossRef]
  46. Friedlander, Y.; Vatta, M.; Sotoodehnia, N.; Sinnreich, R.; Li, H.; Manor, O.; Towbin, J.A.; Siscovick, D.S.; Kark, J.D. Possible association of the human KCNE1 (minK) gene and QT interval in healthy subjects: evidence from association and linkage analyses in Israeli families. Ann. Hum. Genet. 2005, 69, 645–656. [Google Scholar] [CrossRef]
  47. Ellinor, P.T.; Petrov-Kondratov, V.I.; Zakharova, E.; Nam, E.G.; MacRae, C.A. Potassium channel gene mutations rarely cause atrial fibrillation. BMC Med. Genet. 2006, 7, 70. [Google Scholar] [CrossRef]
  48. Wu, DM; Lai, LP; Zhang, M. Characterization of an LQT5-related mutation in KCNE1, Y81C: implications for a role of KCNE1 cytoplasmic domain in IKs channel function. Heart Rhythm 2006, 3, 1031–1040. [Google Scholar] [CrossRef]
  49. Millat, G.; Chevalier, P.; Restier-Miron, L.; Da Costa, A.; Bouvagnet, P.; Kugener, B.; Fayol, L.; Gonzàlez Armengod, C.; Oddou, B.; Chanavat, V.; Froidefond, E.; Perraudin, R.; Rousson, R.; Rodriguez-Lafrasse, C. Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome. Clin. Genet. 2006, 70, 214–227. [Google Scholar] [CrossRef]
  50. Schulze-Bahr, E.; Schwarz, M.; Hauenschild, S.; Wedekind, H.; Funke, H.; Haverkamp, W.; Breithardt, G.; Pongs, O.; Isbrandt, D. A novel long-QT 5 gene mutation in the C-terminus (V109I) is associated with a mild phenotype. J. Mol. Med. 2001, 79, 504–509. [Google Scholar] [CrossRef]
  51. Splawski, I.; Shen, J.; Timothy, K.W.; Lehmann, M.H.; Priori, S.; Robinson, J.L.; Moss, A.J.; Schwartz, P.J.; Towbin, J.A.; Vincent, G.M.; Keating, M.T. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000, 102, 1178–1185. [Google Scholar] [CrossRef]
  52. Campbell, C.A.; Della Santina, C.C.; Meyer, N.C.; Smith, N.B.; Myrie, O.A.; Stone, E.M.; Fukushima, K.; Califano, J.; Carey, J.P.; Hansen, M.R.; Gantz, B.J.; Minor, L.B.; Smith, R.J. Polymorphisms in KCNE1 or KCNE3 are not associated with Ménière disease in the Caucasian population. Am. J. Med. Genet. A 2010, 152A, 67–74. [Google Scholar] [CrossRef]
  53. Tesson, F.; Donger, C.; Denjoy, I.; Berthet, M.; Bennaceur, M.; Petit, C.; Coumel, P.; Schwarts, K.; Guicheney, P. Exclusion of KCNE1 (IsK) as a candidate gene for Jervell and Lange-Nielsen syndrome. J. Mol. Cell. Cardiol. 1996, 28, 2051–205. [Google Scholar] [CrossRef]
  54. Jongbloed, R.; Marcelis, C.; Velter, C.; Doevendans, P.; Geraedts, J.; Smeets, H. DHPLC analysis of potassium ion channel genes in congenital long QT syndrome. Hum. Mutat. 2002, 20, 382–391. [Google Scholar] [CrossRef]
  55. Herlyn, H.; Zechner, U.; Oswald, F.; Pfeufer, A.; Zischler, H.; Haaf, T. Positive selection at codon 38 of the human KCNE1 (= minK) gene and sporadic absence of 38Ser-coding mRNAs in Gly38Ser heterozygotes. BMC Evol. Biol. 2009, 9, 188. [Google Scholar] [CrossRef]
  56. Nishio, Y.; Makiyama, T.; Itoh, H.; Sakaguchi, T.; Ohno, S.; Gong, Y.Z.; Yamamoto, S.; Ozawa, T.; Ding, W.G; Toyoda, F.; Kawamura, M.; Akao, M.; Matsuura, H.; Kimura, T.; Kita, T.; Horie, M. D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. J. Am. Coll. Cardiol. 2009, 54, 812–819. [Google Scholar] [CrossRef]
  57. Jones, M. A discussion on the etiology of tinnitus aurium. Br. Med. J. 1890, 2, 667–672. [Google Scholar] [CrossRef]
  58. Paulussen, A.D.; Gilissen, R.A.; Armstrong, M.; Doevendans, P.A.; Verhasselt, P.; Smeets, H.J.; Schulze-Bahr, E.; Haverkamp, W.; Breithardt, G.; Cohen, N.; Aerssens, J. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J. Mol. Med. 2004, 82, 182–188. [Google Scholar] [CrossRef]
  59. Aydin, A.; Bähring, S.; Dahm, S.; Guenther, U.P.; Uhlmann, R.; Busjahn, A.; Luft, F.C. Single nucleotide polymorphism map of five long-QT genes. J. Mol. Med. 2005, 83, 159–165. [Google Scholar] [CrossRef]
  60. Gouas, L.; Nicaud, V.; Chaouch, S.; Berthet, M.; Forhan, A.; Tichet, J.; Tiret, L.; Balkau, B.; Guicheney, P. Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. Eur. J. Hum. Genet. 2007, 15, 974–979. [Google Scholar] [CrossRef]
  61. Tian, C.; Vanoye, C.G.; Kang, C.; Welch, R.C.; Kim, H.J.; George, A.L., Jr.; Sanders, C.R. Preparation, functional characterization, and NMR studies of human KCNE1, a voltage-gated potassium channel accessory subunit associated with deafness and long QT syndrome. Biochemistry 2007, 46, 11459–11472. [Google Scholar]
  62. Gouas, L.; Nicaud, V.; Berthet, M.; Forhan, A.; Tiret, L.; Balkau, B.; Guicheney, P.; D.E.S.I.R. Study Group. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur. J. Hum. Genet. 2005, 13, 1213–1222. [Google Scholar] [CrossRef]
  63. Akyol, M.; Jalilzadeh, S.; Sinner, M.F.; Perz, S.; Beckmann, B.M.; Gieger, C.; Illig, T.; Wichmann, H.E.; Meitinger, T.; Kääb, S.; Pfeufer, A. The common non-synonymous variant G38S of the KCNE1-(minK)-gene is not associated to QT interval in Central European Caucasians: results from the KORA study. Eur. Heart J. 2007, 28, 305–309. [Google Scholar] [CrossRef]
  64. Marjamaa, A.; Newton-Cheh, C.; Porthan, K.; Reunanen, A.; Lahermo, P.; Väänänen, H.; Jula, A.; Karanko, H.; Swan, H.; Toivonen, L.; Nieminen, M.S.; Viitasalo, M.; Peltonen, L.; Oikarinen, L.; Palotie, A.; Kontula, K.; Salomaa, V. Common candidate gene variants are associated with QT interval duration in the general population. J. Intern. Med. 2009, 265, 448–458. [Google Scholar] [CrossRef]

Share and Cite

MDPI and ACS Style

Sand, P.G.; Luettich, A.; Kleinjung, T.; Hajak, G.; Langguth, B. An Examination of KCNE1 Mutations and Common Variants in Chronic Tinnitus. Genes 2010, 1, 23-37. https://doi.org/10.3390/genes1010023

AMA Style

Sand PG, Luettich A, Kleinjung T, Hajak G, Langguth B. An Examination of KCNE1 Mutations and Common Variants in Chronic Tinnitus. Genes. 2010; 1(1):23-37. https://doi.org/10.3390/genes1010023

Chicago/Turabian Style

Sand, Philipp G., Alexander Luettich, Tobias Kleinjung, Goeran Hajak, and Berthold Langguth. 2010. "An Examination of KCNE1 Mutations and Common Variants in Chronic Tinnitus" Genes 1, no. 1: 23-37. https://doi.org/10.3390/genes1010023

APA Style

Sand, P. G., Luettich, A., Kleinjung, T., Hajak, G., & Langguth, B. (2010). An Examination of KCNE1 Mutations and Common Variants in Chronic Tinnitus. Genes, 1(1), 23-37. https://doi.org/10.3390/genes1010023

Article Metrics

Back to TopTop